Psoriasis Clinical Trial

T Cell Repertoire Analysis of Immune Mediated Skin Diseases

Summary

This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge about immune mediated skin disease.

View Full Description

Full Description

The aim of the study is to characterized the T cell repertoire of individuals with immune mediated skin disease (e.g. psoriasis and mycosis fungoides). Peripheral blood with be collected from volunteers with psoriasis, mycosis fungoides and age matched controls. Fifteen tablespoons of blood will be collected prior to the initiation of treatment and again after the patient shows a clinical response to treatment. The time between blood draws will be no less than 3 months. There will be no more than two blood draws per patient. Blood samples will be used to determine the patient's HLA haplotype via PCR and DNA sequencing. After the patient's haplotype has been established the activated T cell repertoire will be analyzed for clonal expansions. Clonal expansions in the T cell repertoire will be determined by immunoscope analysis, which is a PCR based technique.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have an immune mediated skin disease, such as psoriasis or mycosis fungoides
Are not taking immunosuppressive medications, which may interfere with T cell analysis.

Exclusion Criteria:

are taking immunosuppressive medications, which may interfere with T cell analysis

Study is for people with:

Psoriasis

Estimated Enrollment:

426

Study ID:

NCT00368784

Recruitment Status:

Completed

Sponsor:

University of California, Davis

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California, Davis Department of Dermatology
Sacramento California, 95816, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

426

Study ID:

NCT00368784

Recruitment Status:

Completed

Sponsor:


University of California, Davis

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider